GlassScriptPhysician profile
Hillary L Templeton
NPI 1992302038
$1,652.80
in general payments reported to CMS, 2019-2025
25 companies · $13.93 in 2025
The $13.93 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $756 · 2022: $389 · 2023: $475 · 2024: $19.19 · 2025: $13.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $339.51 | 2021-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $328.79 | 2021-2025 | |
| Lilly USA, LLC | $190.96 | 2021-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $122.78 | 2021-2023 | Fasenra, Farxiga |
| Supernus Pharmaceuticals, INC. | $122.54 | 2021 | |
| Pfizer INC. | $79.69 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $73.15 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.05 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $48.97 | 2022-2023 | Rexulti |
| Amarin Pharma, INC. | $37.21 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.51 | 2021-2022 | |
| Nevro Corp. | $20.79 | 2023 | Senza |
| Seqirus USA INC | $19.33 | 2022 | |
| Glaxosmithkline, LLC. | $17.64 | 2023 | Shingrix, Arexvy |
| Mylan Specialty L.P. | $17.34 | 2023 | Yupelri |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $17.10 | 2023 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $16.47 | 2023 | Seglentis |
| Astellas Pharma US INC | $16.29 | 2023 | Myrbetriq |
| Exact Sciences Corporation | $16.26 | 2023 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $15.87 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.34 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.71 | 2021 | |
| Intra-Sana Laboratories | $14.39 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Sanofi Pasteur INC. | $13.37 | 2023 | |
| Genentech USA, INC. | $5.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Templeton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.